Skip to main navigation Skip to search Skip to main content

A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and adults

Project: Research

Project Details

StatusFinished
Effective start/end date03/31/15 → 03/30/17

Funding

  • GW Research Limited: $157,863.98